MEGAN CAMPBELL: Open Payments
NPI 1821258583 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$592 in 19 payments from 10 companies in 2025. Trend: 2023 $372 · 2024 $626 · 2025 $592
Food & beverage: $592
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $261 |
| Medtronic, Inc. | 1 | $153 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Merck Sharp & Dohme LLC | 1 | $28 |
| Optinose US, Inc. | 1 | $23 |
| Smith+Nephew, Inc. | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Hikma Pharmaceuticals USA | 1 | $15 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $14 |
Products named: DUPIXENT, STEALTHSTATION S8 PLATFORM, Xhance, STRAVIX, NUCALA, Ryaltris, NEFFY.
Industry payments across NC — which companies pay providers there.
